Stay updated on Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial

Sign up to get notified when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new version entry (Version 26, submitted 2025-08-12) appears in the history, reflecting updated study status and recruitment details for NCT05516498.
    Difference
    0.1%
    Check dated 2025-10-27T21:04:00.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    11%
    Check dated 2025-10-06T08:30:44.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.3%
    Check dated 2025-09-29T05:15:34.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Patch update: the page revision moves from v3.0.1 to v3.0.2. The 'Back to Top' element has been removed, with no substantive changes to core content, pricing, stock, or time slot information.
    Difference
    0.7%
    Check dated 2025-09-14T23:34:05.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.7%
    Check dated 2025-09-07T20:13:35.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This indicates a shift towards a more generalized presentation of location data.
    Difference
    27%
    Check dated 2025-08-31T12:53:48.000Z thumbnail image

Stay in the know with updates to Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Zibotentan/Dapagliflozin Combo in Liver Cirrhosis Clinical Trial page.